PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1401365
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1401365
Global Dermatophytic Onychomycosis Treatment Market is valued at approximately USD 4.68 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.0% over the forecast period 2023-2030. Dermatophytic onychomycosis, also known as fungal nail infection, is a common condition caused by various types of fungi, primarily dermatophytes. It affects the nails, causing them to become discolored, brittle, and thickened. It constitutes approximately one-third of all fungal infections worldwide, with dermatophytes responsible for around 70%-80% of these cases. This growing prevalence has led to a rising need for medications designed to treat dermatophytic onychomycosis. The growing cases of diabetes, increasing awareness of dermatophytic onychomycosis and its treatment, as well as surging demand for topical treatments are the most prominent factors that are propelling the market demand across the globe.
In addition, the increasing aging population, coupled with the growing prevalence of onychomycosis globally are the leading factors that are accelerating the market growth during the estimated period. According to a 2020 article titled "High Prevalence of Mixed Infections in Global Onychomycosis," the global prevalence of onychomycosis is estimated to be around 10%, with Trichophyton rubrum being the most commonly identified causative organism. Also, as per the NCBI article published in 2022, onychomycosis accounts for roughly half of all nail-related disorders and affects approximately 5.5% of the global population. Furthermore, data from the World Health Organization (WHO) in 2021 indicates that by 2030, approximately one in every six individuals globally will be aged 60 years or older. The number of individuals aged 60 and above is projected to increase from 1 billion in 2020 to 1.4 billion by 2050, effectively doubling the global population of adults aged 60 and over to 2.1 billion by 2050. Moreover, the increasing government support for research and development, as well as the rising introduction of new and innovative treatments presents various lucrative opportunities over the forecast years. However, the high cost of treatment and the side effects of treatment are hindering the market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Dermatophytic Onychomycosis Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing investment in R&D activities, the introduction of generic versions of oral antifungal medications, along with the growing awareness about the impact of fungal nail infections. Whereas, Asia Pacific is expected to grow at the fastest CAGR over the forecast years. The rising healthcare expenditure, increasing prevalence of onychomycosis, and diabetic patient populations are significantly propelling the market demand across the region.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of tables and figures and dummy in nature, final lists may vary in the final deliverable